Principal Scientist
Navigate Biopharma
Carlsbad, California
Mark Blimline, M.S., is a Principal Scientist (Ligand Binding Assay Technologies) at Navigate Biopharma. Mark joined Navigate in 2018 and brings over 12 years of CRO industry experience developing and validating biomarker, PK and immunogenicity assays, with a focus on cell-based and multiplex biomaker assays to support cell and gene therapy product filings.
Scientific Challenges Developing Bioanalytical Assays for Novel Modalities: Car-T
Tuesday, October 24, 2023
10:30 AM – 11:00 AM ET